Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention

Lidija Savic1,2, Igor Mrdovic1,2, Milika Asanin1,2

  • 1Faculty of Medicine, University of Belgrade, Beograd, Serbia.

Insights

Sudden cardiac death (SCD) incidence is low in unselected ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI). Key predictors include reduced ejection fraction, poor post-procedural blood flow, and elevated Killip class.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Previous studies on sudden cardiac death (SCD) predictors often focused on high-risk acute myocardial infarction (MI) patients.
  • Limited data exists on SCD predictors in unselected ST-elevation myocardial infarction (STEMI) populations undergoing primary percutaneous coronary intervention (pPCI).

Purpose of the Study:

  • To determine the incidence of SCD in unselected STEMI patients treated with pPCI.
  • To identify independent predictors of SCD during a 6-year follow-up period.

Main Methods:

  • Analysis of 3114 STEMI patients from the University Clinical Center of Serbia STEMI Register.
  • Exclusion of patients with cardiogenic shock; echocardiography performed before hospital discharge.
  • 6-year follow-up to record lethal outcomes and SCD events.

Main Results:

  • Overall lethal outcome in 9.5% of patients; SCD accounted for 31.9% of deaths (95 patients).
  • Highest SCD incidence occurred in the first year (0.8% of analyzed patients).
  • Independent SCD predictors identified: ejection fraction < 45%, post-procedural TIMI flow < 3, reduced kidney function, and Killip class > 1.

Conclusions:

  • Unselected STEMI patients treated with pPCI exhibit a low incidence of SCD.
  • Predictors of long-term SCD risk are readily available during index hospitalization.
  • Key predictors include low ejection fraction, impaired post-procedural coronary flow, higher Killip class, and reduced kidney function.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
21
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
22
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
47
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22